Compound ID | 1019
Class: Natural small molecule
| Details of activity: | Antitumour antibiotic, limited activity against bacteria |
| Propensity to select resistant mutants: | No |
| Institute where first reported: | Squib Institute for medical research, New Brunswick, New Jersey |
| Year first mentioned: | 1966 |
| Highest development stage: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: | http://pubs.acs.org/doi/abs/10.1021/jm00314a044 |